ARN largos no codificantes séricos para detección temprana de cáncer de estómago en Perú

Manuel Hidalgo; Pablo Chuna-Mogollón; Edinson Larco-León; Cynthia Ramos

doi:10.35434/rcmhnaaa.2023.163.2017

Autores/as

Manuel Hidalgo Programa de Estudio de Medicina Humana, Universidad Privada Antenor Orrego, Trujillo, Perú.
Pablo Chuna Mogollón Departamento Académico de Ciencias, Universidad Privada Antenor Orrego, Trujillo, Perú
Edinson Larco-León Departamento Académico de Ciencias, Universidad Privada Antenor Orrego, Trujillo, Perú
Cynthia Ramos Programa de Estudio de Medicina Humana, Universidad Privada Antenor Orrego, Trujillo, Perú.

DOI:

https://doi.org/10.35434/rcmhnaaa.2023.163.2017

Palabras clave:

ARN largos no codificantes, cáncer de estómago, detección temprana

Descargas

Los datos de descargas todavía no están disponibles.

Métricas

Cargando métricas ...

Biografía del autor/a

Manuel Hidalgo, Programa de Estudio de Medicina Humana, Universidad Privada Antenor Orrego, Trujillo, Perú.

Magister Scientiae en Mejoramiento Genético de Plantas

Pablo Chuna Mogollón, Departamento Académico de Ciencias, Universidad Privada Antenor Orrego, Trujillo, Perú

Magister Scientiae en Medicina Veterinaria

Edinson Larco-León, Departamento Académico de Ciencias, Universidad Privada Antenor Orrego, Trujillo, Perú

Maestro en Fisiología

Cynthia Ramos, Programa de Estudio de Medicina Humana, Universidad Privada Antenor Orrego, Trujillo, Perú.

Magister Scientiae en Mejoramiento Genético de Plantas

Citas

Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249. doi: 10.3322/CAAC.21660

MINSA (Ministerio de Salud). (2013). Análisis de la Situación del Cáncer en el Perú, 2013. Lima: Dirección General de Epidemiología, MINSA; 2013.

Toh JWT, Wilson RB. (2020). Pathways of Gastric Carcinogenesis, Helicobacter pylori Virulence and Interactions with Antioxidant Systems, Vitamin C and Phytochemicals. Int J Mol Sci. 2020 Sep 3;21(17):6451. doi: 10.3390/ijms21176451

Park Y.H., Kim N. (2015). Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancer. J. Cancer Prev. 2015;20:25–40. doi: 10.15430/JCP.2015.20.1.25.

Nies AT, Magdy T, Schwab M, Zanger UM. (2015). Role of ABC transporters in fluoropyrimidine-based chemotherapy response. Adv Cancer Res. 2015;125:217–243. doi: 10.1016/bs.acr.2014.10.007

Wei L, Sun J, Zhang N, et al. (2020). Noncoding RNAs in gastric cancer: implications for drug resistance. Mol Cancer. 2020 Mar 19;19(1):62. doi: 10.1186/s12943-020-01185-7.

Rugge M; Fassan M; Graham DY. (2015). Epidemiology of Gastric Cancer. Gastric Cancer. 2015. 23–34. doi: 10.1007/978-3-319-15826-6_2

Torres-Román JS, Grados-Sánchez O. (2015). Cáncer gástrico en el Perú: una realidad susceptibilidad de cambio [carta]. Rev Gastroenterol Peru. 2015;35(3):276

Chen YC; Fang WL; Wang RF; et al. (2016). Clinicopathological Variation of Lauren Classification in Gastric Cancer. Pathol Oncol Res. 2016; 22(1): 197–202. doi: 10.1007/s12253-015-9996-6.

Miaozhen Q; Zhou Y; Zhang et al. (2014). Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patients. BMC Cancer. 2014; 14(823). doi: 10.1186/1471-2407-14-823.

Sexton RE, Al Hallak MN, Diab M, Azmi AS. (2020). Gastric cancer: a comprehensive review of current and future treatment strategies. Cancer Metastasis Rev. 2020 Dec;39(4):1179-1203. doi: 10.1007/s10555-020-09925-3.

Beylerli O, Gareev I, Sufianov A, Ilyasova T, Guang Y. (2022). Long noncoding RNAs as promising biomarkers in cancer. Noncoding RNA Res. 2022 Feb 25;7(2):66-70. doi: 10.1016/j.ncrna.2022.02.004.

Zhong, Y., Xu, F., Wu, J., Schubert, J., & Li, M. M. (2021). Application of Next Generation Sequencing in Laboratory Medicine. Annals of laboratory medicine, 41(1), 25–43. https://doi.org/10.3343/alm.2021.41.1.25

Jarroux, J., Morillon, A. and Pinskaya, M. (2017) Long Non Coding RNA Biology. doi: 10.1007/978-981-10-5203-3.

Han, S. et al. (2018) ‘LncFinder: an integrated platform for long non-coding RNA identification utilizing sequence intrinsic composition, structural information and physicochemical property’, Briefings in Bioinformatics, (May), pp. 1–19. doi: 10.1093/bib/bby065.

Rinn, J. L. and Chang, H. Y. (2012) ‘Genome regulation by long noncoding RNAs.’, Annual review of biochemistry, 81, pp. 145–66. doi: 10.1146/annurev-biochem-051410-092902.

Kiegle, E. A. et al. (2018) ‘A Genomic View of Alternative Splicing of Long Non-coding RNAs during Rice Seed Development Reveals Extensive Splicing and lncRNA Gene Families’, Frontiers in Plant Science, 9(February), pp. 1–12. doi: 10.3389/fpls.2018.00115.

Yu, T. and Zhu, H. (2019) ‘Long Non-Coding RNAs: Rising Regulators of Plant Reproductive Development’, Agronomy, 9(2), p. 53. doi: 10.3390/agronomy9020053.

Silva A., Bullock M., Calin G. (2015). The clinical relevance of long non-coding RNAs in cancer. Cancers. 2015;7(4):2169–2182. doi: 10.3390/cancers7040884.

Zhu X, Han W, Xue W, et al. (2016). The association between telomere length and cancer risk in population studies. Sci Rep. 2016;6:22243. doi: 10.1038/srep22243

Hashad D., Elbanna A., Ibrahim A., et al. (2016). Evaluation of the role of circulating long non-coding RNA H19 as a promising novel biomarker in plasma of patients with gastric cancer. J. Clin. Lab. Anal. 2016;30(6):1100–1105. doi: 10.1002/jcla.2016.30.issue-6.

Jin C.J., Shi W., Wang F., et al. (2016). Long non-coding RNA HULC as a novel serum biomarker for diagnosis and prognosis prediction of gastric cancer. Oncotarget. 2016;7(32):51763–51772. doi: 10.18632/oncotarget.10107

Dong L, Qi P, Xu MD, et al. (2015). Circulating CUDR, LSINCT-5 and PTENP1 long noncoding RNAs in sera distinguish patients with gastric cancer from healthy controls. Int J Cancer. 2015 Sep 1;137(5):1128-35. doi: 10.1002/ijc.29484.